Evaluation of cardioprotective effect of Aegle marmelos on doxorubicin induced cardiotoxicity: an experimental study

Pinki Vishwakarma, Pratik Divekar, Raj Kumar Goel, Monica Sharma, Manish Saini, K. K. Saxena


Background: Aegle marmelos (A. marmelos), a medicinal herb, is widely used in the Indian system of medicine for treatment of various ailments. The methanolic extract of A. marmelos leaves had shown antioxidant effect. However, so far aqueous extract of A. marmelos is not scientifically evaluated for its cardio protective potential. Hence the present study was designed to find out cardio protective role of A. marmelos against doxorubicin induced cardiotoxicity.

Methods: Thirty rats were randomized into five major groups (n=6). Group I received only 2ml/100g/day normal saline p.o., group II received 2ml/100g/day of normal saline p.o. followed by doxorubicin on 21st day, group III received carvedilol 30 mg/kg/day p.o., Group IV received A. marmelos 250mg/kg/day p.o. and Group V received A. marmelos 500mg/kg/day p.o. for 21days. Doxorubicin 20mg/kg i.p. single dose was given to induce cardiotoxicity in rats of group II, III, IV and V respectively on last day of experiment. Animals were sacrificed 48 hours after doxorubicin administration. Cardiac serum markers creatinine phosphokinase MB, lactate dehydrogenase, serum glutamate oxaloacetate transaminase and serum glutamate pyruvate transaminase were analysed biochemically. Histopathological changes were studied under light microscope.

Results: All cardiac serum marker levels were found significantly (p<0.001) increased in doxorubicin group while A. marmelos pre-treated group displayed significant (p<0.001) reduction in rise of these parameters in a dose dependent manner indicating cardio protection. Histological observations further correlated the cardio protective effect of A. marmelos.

Conclusions: The present study concluded that aqueous extract of A. marmelos possesses cardio protective potential against doxorubicin induced cardiotoxicity.


Aegle marmelos, Cardio toxicity, Carvedilol, Doxorubicin

Full Text:



Prabhakaran D, Jeemon P, Roy A, Cardiovascular diseases in India, current epidemiology and future directions. Circulation. 2016;133:1605-20.

Schimmel KJ, Richel DJ, Van Den Brink RB, Guchelar HJ. Cardiotoxicity of cytotoxic drugs. Cancer Treat Rev. 2004;30:181-91.

Matsui H, Morishima I, Numaguchi Y, Toki Y, Okumura K, Hayakawa T. protective effects of Carvedilol against doxorubicin-induced cardiomyopathy. Life Sci. 1999;65(2):1265-74.

Karwacki Z, Kowianski P, Morys J. General anaesthesia in rats undergoing experiments on the central nervous system: Folia Morphol. 2001;60(4):235-42.

Talib VH. A handbook of medical laboratory technology. 2nd Ed. New Delhi: CBS Publisher and Distributors; 2007:155-167.

Clayden EC, editor. Practical section cutting and staining- part 1, London: Churchill Livingstone; 1971:1071.

Deavall DG, Martin EA, Horner JM, Roberts R. Drug-induced oxidative stress and toxicity. J. Toxicol. 2012;13.

Byrne JA, Grieve DJ, Cave AC, Shah AM. Oxidative stress and heart failure. Arch Mal Coeur. 2003;96:214-21.

Haed S, Barshack I, Luboshits G, Wexler D, Deutsch V, Keren G, et al. Erythropoietin improves myocardial performance in doxorubicin-induced Cardiomyopathy. Eur. Heart J. 2006;27:1876-83.

Yilmaz S, Atessahin A, Sahna E, Karahan I, Ozer S. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity. Toxicology. 2006;218:164-71.

Krishnamurthy B, Rani N, Bharti S, Golechha M, Bhatia J, Nag TC, et al. Febuxostat ameliorates doxorubicin-induced cardio toxicity in rats Chem Biol Interact. 2015;237:96-103.

Subburaman S, Ganesan K, Ramachandran M. Protective role of naringenin against doxorubicin- induced cardio toxicity in a rat model: histopathology and mRNA expression profile studies. Food Chem Toxicol. 2010;48(5):1178-84.

Baliga MS, Bhat HP, Pereira MM, Mathias N, Venkatesh P. Radioprotective effects of Aegle marmelos (L.) Correa (Bael): a concise review. J Altern Complement Med. 2010;16:1109-16.

Suchalatha S, Devi SCS. Protective effect of terminalia chebula against experimental myocardial injury induced by isoproterenol. Indian Biol. 2004;42:174-8.

Panda VS, Naik SR. Cardioprotective activity of ginkgo biloba phytosomes in isoproterenol induced myocardial necrosis in rats: a biochemical and histoarchitectural evaluation. Exp Toxicol Pathol. 2008;60:397-404.

Farvin KHS, Anandan R, Kumar SH, Shiny KS, Sanka TV, Thankappan TK. Effect of squalene on tissue defense system in isoproterenol-induced myocardial infarction in rats. Pharmacol Res. 2004;50:231-36.

Garba IH, Ubom GA. Total serum lactate dehydrogenase activity in acute Plasmodium falciparum malaria infection. Singapore Med J. 2005;46:632-4.

Dewar HA, Rowell NR, Smith AJ. Serum glutamic oxaloacetic transaminase in acute myocardial infarction. Brt Med J. 1958;8:1121-5.

Hayward R, Hydock DS. Doxorubicin cardiotoxicity in rats: an in vivo characterization. J Am Assoc Lab Anim Sci. 2007 July;46(4):20-32.